Clinical Trial Update: DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) [Phase 4]

View source ↗

Summary

Phase 4 trial update on direct-acting antiviral–based therapy for recently acquired Hepatitis C, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Kirby Institute | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2016-10-20